BGM Group Ltd. (BGM) vs NRx Pharmaceuticals, Inc. (NRXP)

A side-by-side comparison of BGM Group Ltd. and NRx Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BGM

BGM Group Ltd.

$122M

$9.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

NRXP

NRx Pharmaceuticals, Inc.

$127M

$2.94HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BGM vs NRXP

growth of $100 · dividends reinvested · last 2y

BGM -94.3% (-76.2%/yr)NRXP +33.5% (+15.5%/yr)NRXP compounded faster over this window

Log scale — wide-divergence pair

BGM NRXP

BGM vs NRXP: by the numbers

•NRXP is the larger company ($127M vs $122M market cap).
•Both run net losses; BGM's is the smaller (-52.59% vs -691.81% net margin).

Metrics side by side

Valuation

Metric	BGM	NRXP
P/S ratio	N/A	37.50
P/B ratio	0.31	N/A

Profitability

Metric	BGM	NRXP
Gross margin	12.79%	58.78%
Operating margin	-33.18%	-1324.41%
Net margin	-52.59%	-691.81%
ROE	-5.10%	N/A
ROIC	-3.19%	N/A

Growth (annualized)

Metric	BGM	NRXP
Revenue CAGR (5Y)	-5.39%	N/A
Total return CAGR (5Y)	N/A	-49.61%

Go deeper

Full BGM analysis Full NRXP analysis Interactive comparison tool

Dig into the metrics

BGM ROE NRx Pharmaceuticals ROE BGM operating margin NRx Pharmaceuticals operating margin BGM revenue growth NRx Pharmaceuticals revenue growth BGM free cash flow NRx Pharmaceuticals free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.